Insider Transactions in Q2 2021 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Mark J Foley CEO |
BUY
Other acquisition or disposition
|
Direct |
882
+0.11%
|
$21,168
$24.09 P/Share
|
|
Jun 30
2021
|
Tobin Schilke CFO |
BUY
Other acquisition or disposition
|
Direct |
446
+0.64%
|
$10,704
$24.09 P/Share
|
|
Jun 30
2021
|
Dustin S Sjuts President |
BUY
Other acquisition or disposition
|
Direct |
882
+1.32%
|
$21,168
$24.09 P/Share
|
|
May 05
2021
|
Jill Beraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+17.43%
|
-
|
|
May 05
2021
|
Julian S Gangolli Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+16.36%
|
-
|
|
May 05
2021
|
Carey O Connor Kolaja Director |
BUY
Grant, award, or other acquisition
|
Direct |
674
+8.82%
|
-
|
|
May 05
2021
|
Chris Nolet Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+17.43%
|
-
|
|
May 05
2021
|
Angus C. Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+16.36%
|
-
|
|
May 05
2021
|
Philip J. Vickers Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,013
+14.5%
|
-
|
|
May 05
2021
|
Olivia C Ware Director |
BUY
Grant, award, or other acquisition
|
Direct |
674
+8.69%
|
-
|
|
Apr 15
2021
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
411
-0.63%
|
$11,508
$28.16 P/Share
|
|
Apr 05
2021
|
Aubrey Rankin Director |
SELL
Open market or private sale
|
Indirect |
2
-0.0%
|
$56
$28.28 P/Share
|